Roberto Salgado
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Inflammatory Biomarkers in Disease Prognosis
- Chemokine receptors and signaling
- Cytokine Signaling Pathways and Interactions
- Cancer Immunotherapy and Biomarkers
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Papers in
- Oncology 25
- Cancer Immunotherapy and Biomarkers 8
- Inflammatory Biomarkers in Disease Prognosis 5
- Lymphatic System and Diseases 4
- Cancer Cells and Metastasis 4
- Cancer Treatment and Pharmacology 3
-
- Cancer Genomics and Diagnostics 7
- Breast Cancer Treatment Studies 6
- Co-authors
- Ina Benoy (9 shared papers)Eric Van Marck (5 shared papers)Peter Vermeulen (7 shared papers)Peter A. van Dam (7 shared papers)Luc Dirix (6 shared papers)Reinhilde Weytjens (5 shared papers)Cécile Colpaert (4 shared papers)P. Huget (3 shared papers)
- Journals
- British Journal of Cancer (5 papers)Annals of Oncology (3 papers)Journal of Clinical Oncology (3 papers)Cancer Research (3 papers)Clinical Cancer Research (1 paper)
- Partner nations
- BelgiumUnited StatesAustralia
In The Last Decade
Roberto Salgado
31 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 105
- Oncology 893
- Internal Medicine 115
- Cancer Research 356
- Immunology 271
- Hematology 90
Countries citing papers authored by Roberto Salgado
This map shows the geographic impact of Roberto Salgado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Salgado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Salgado more than expected).
Fields of papers citing papers by Roberto Salgado
This network shows the impact of papers produced by Roberto Salgado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Salgado. The network helps show where Roberto Salgado may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Salgado, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 339 | |
| 2 | 2004 | 287 | |
| 3 | 2002 | 165 | |
| 4 | 2004 | 151 | |
| 5 | 2002 | 147 | |
| 6 | 1999 | 143 | |
| 7 | 2002 | 52 | |
| 8 | 2011 | 36 | |
| 9 | 2018 | 34 | |
| 10 | 2005 | 28 | |
| 11 | 2019 | 17 | |
| 12 | 2004 | 13 | |
| 13 | 1985 | 13 | |
| 14 | 1998 | 10 | |
| 15 | 2001 | 9 | |
| 16 | 2018 | 8 | |
| 17 | 2019 | 6 | |
| 18 | 2000 | 6 | |
| 19 | 2015 | 5 | |
| 20 | 2019 | 5 |
About Roberto Salgado
Roberto Salgado is a scholar working on Oncology, Cancer Research, Molecular Biology, Surgery and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 1.5k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (10 papers), Cancer Immunotherapy and Biomarkers (8 papers), Cancer Genomics and Diagnostics (7 papers), Breast Cancer Treatment Studies (6 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), Lymphatic System and Diseases (4 papers), Cancer Cells and Metastasis (4 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Oncology (893 citations), Internal Medicine (115 citations), Cancer Research (356 citations), Immunology (271 citations) and Hematology (90 citations). Roberto Salgado has collaborated with scholars based in Belgium, United States and Australia. Frequent co-authors include Ina Benoy, Eric Van Marck, Peter Vermeulen, Peter A. van Dam, Luc Dirix, Luc Dirix, Reinhilde Weytjens, Cécile Colpaert, P. Huget and Philippe Huget. Their work appears in journals such as British Journal of Cancer, Annals of Oncology, Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.